Biosimilars in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026

Professor Tore K. Kvien explores the evolving landscape of biosimilars and their vital role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights clinical application, access strategies, and the overall impact of biosimilar therapies in improving patient outcomes and healthcare sustainability on a global scale.

Video: https://medicaldigest.org/scientific-contents/interview:biosimilars-focus-advancing-global-health-rheumatology